Contact

Category: Oppenheimer

  • Oppenheimer maintains Outperform rating on Jasper Therapeutics shares By Investing.com

    •

    Investor Empires

    Oppenheimer maintained a positive outlook on Jasper Therapeutics (NASDAQ: JSPR), reiterating an Outperform rating with a firm price target of $80.00. The company’s position comes after evaluating long-term results from a phase 2 study of parzolfolimab for the treatment of chronic spontaneous urticaria (CSU), which was presented at the European…

  • Oppenheimer sees more favorable setup for consumer staples stocks By Investing.com

    •

    Investor Empires

    Oppenheimer analysts see a more favorable setup for consumer staples stocks as the market anticipates a rate cut from the Federal Reserve. “Fed easing has historically been positive for consumer staples stocks, and the group has generally outperformed during periods of low 10-year Treasury yields,” Oppenheimer wrote. Their analysis shows…

  • Palo Alto Networks target raised by Oppenheimer on strong FY24 By Investing.com

    •

    Investor Empires

    Oppenheimer saw its price target on Palo Alto Networks (NASDAQ:NASDAQ:) increase from $390.00 to $410.00, while the company maintained an outperform rating on the stock. This adjustment comes after Palo Alto Networks delivered a strong performance at the end of its fiscal 2024, beating estimates with strong platform sales. Palo…

  • Gossamer Bio a new outperform at Oppenheimer on seralutinib for PAH

    •

    Investor Empires

    George Clerk Oppenheimer launched Gossamer Bio into an outperformance expressing optimism about seralutinib, an inhaled tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension (PAH). The company has a price target of $9 (~984% upside based on June 24 close). Analyst Andreas Argyrides said that the safety of the…

  • Oppenheimer raises Utilities sector rating, cuts Real Estate By Investing.com

    •

    Investor Empires

    Oppenheimer analysts raised their rating on the utilities sector and downgraded real estate in a broad-based note on Tuesday, citing positive earnings growth. The company highlighted that eight of the 11 sectors in the S&P 500 index are showing earnings growth, with six at double-digit rates. These services include communications…

  • Modine stock upgraded by Oppenheimer on growth drivers By Investing.com

    •

    Investor Empires

    On Thursday, Oppenheimer maintained an outperform rating on Modine Manufacturing (NYSE:) stock and increased its price target to $110 from $105. The revision follows Modine’s mixed Q4 FY2024 results and FY2025 guidance compared to consensus expectations. Despite early trading lows on Wednesday, the company’s shares rose due to several factors…